Last week, Strainprint, a leader in cannabis data and analytics, announced a partnership with Israeli research leaders, Lumir Lab and Gynica to conduct the world’s first international clinical study on the use of cannabis to treat endometriosis. BofC’s Blaine Pearson caught up with Michelle…
Read More
The inaugural Cannabis + Technology presented by Business of Cannabis was held September 27, 2019 in Toronto, Ontario, Canada. The “Driving Decision-Making Through Patient + Consumer Insights” panel was moderated by Mary-Margaret Jones and was comprised of Michelle Arbus of Strainprint,Sean Copeland of Lift&Co. and Alexander Gregory of the Ontario Cannabis Store.…
Michelle Arbus heads up research at Strainprint. She joined BofC Live to provide updates…
Michelle Arbus is the VP/Research at Strainprint Technologies. As such, she oversees research products…
The inaugural Cannabis + Technology presented by Business of Cannabis was held September 27, 2019 in Toronto, Ontario, Canada. The “Driving Decision-Making Through Patient + Consumer Insights” panel was moderated…
More
Michelle Arbus is the VP/Research at Strainprint Technologies. As such, she oversees research products and helps understand, both from a patient and researcher perspective, how, when, why and what patients are using…
More
Michelle Arbus heads up research at Strainprint. She joined BofC Live to provide updates about their research project regarding the use of medical cannabis to treat endometriosis.…
More
Last week, Strainprint, a leader in cannabis data and analytics, announced a partnership with Israeli research leaders, Lumir Lab and Gynica to conduct the world’s first international clinical study on…
More
